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Abstract
We report a case of viral peritonitis caused by coxsackievi-
rus B1 in a 79-year-old male undergoing continuous ambulatory
peritoneal dialysis (CAPD), and review the English language liter-
ature. Clinicians should be aware of viral peritonitis in patients
on CAPD presenting with a viral syndrome and mononuclear
peritoneal dialysis efﬂuent. Currently, viral diagnostic tests are
available to conﬁrm the diagnosis and avoid unnecessary
treatment with antibiotics.
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Peritonitis is one of the major complications of continuous
ambulatory peritoneal dialysis (CAPD). Bacteria cause at
least 70–80% of CAPD-associated peritonitis episodes, and
bacterial cultures remain negative in 20% [1].
Only a few cases of viral CAPD-associated peritonitis have
been reported [2–8]. It is unclear whether viral CAPD-
associated peritonitis is truly infrequent or remains largely
unrecognized because laboratory tests for the detection of
viruses in peritoneal dialysis (PD) efﬂuent or viral antibodies
are not often performed.
We hereby report on an episode of CAPD-associated
peritonitis during the course of a coxsackievirus B1 infection
in a 79-year-old male patient. Previously reported cases of
viral CAPD-associated peritonitis were searched for through
MEDLINE, and are brieﬂy summarized.
Case Description
A 79-year-old man was admitted with respiratory-induced
pain in the left hemithorax (pleurodynia), fever, and malaise
(day 0). Clinical examination revealed a temperature of 38C
and a pre-cordial pleural rub. The patient was treated with
CAPD for 4 months because of end-stage ischaemic vascular
kidney disease. Further medical history was insigniﬁcant, apart
from a multinodular goitre and an inguinal herniorraphy.
The peripheral white blood cell count was 4000/mm3,
with 87.8% neutrophils and a C-reactive protein (CRP) level
of 38.8 mg/L. The PD efﬂuent contained 154 leukocytes/
mm3, with 98.5% monocytes. Owing to this unusual ﬁnding,
and because the patient mentioned that his toddler grand-
daughter had symptoms of a viral infection, i.e. fever, myalgia,
and vesicular lesions of the tongue, the clinician also
requested an analysis of the PD efﬂuent for viral pathogens.
For viral culture, samples were inoculated on RD and MRC5
cell lines. Cultured monolayers showing a typical cytopathic
effect for enteroviruses were examined for the presence of
enteroviruses by means of indirect immunoﬂuorescence
(Monoclonal Mouse anti-Enterovirus Antibody, clone 5-D8/1;
Dako Diagnostics, Glostrup, Denmark). A chest X-ray was
normal, but echocardiography revealed a mild pericardial
effusion. A presumed diagnosis of pericarditis was made, and
acetylsalicylic acid 500 mg three times daily was started
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orally. Empirical cefazolin and amikacin were started for
presumed CAPD peritonitis. The antibiotic therapy was
discontinued on day 3, when the PD efﬂuent culture showed
no bacterial growth. On day 4, the patient had recovered
and was discharged. The CRP level had decreased to
29.8 mg/L. Bacterial, mycobacterial and viral cultures of PD
efﬂuent remained negative.
On day 8, the patient was re-admitted with renewed com-
plaints of malaise and fever. His temperature was 38.6C.
Abdominal examination ﬁndings were unremarkable. The PD
efﬂuent was cloudy, and contained 4590 leukocytes/mm3,
with 91.5% monocytes. The peripheral white blood cell
count was 3400/mm3, with 80% neutrophils, and the CRP
level was 66.8 mg/L. Antibiotics (cefazolin and amikacin)
were restarted. On day 9, the laboratory reported the isola-
tion of an enterovirus from the PD efﬂuent sample of day 0.
The antibiotic therapy was stopped. Another PD efﬂuent
sample was obtained for viral culture and RT-PCR for ente-
roviruses. The in-house PCR technique was as follows: after
RNA extraction with the QIAMP viral RNA MINI Kit
(Qiagen, Venlo, The Netherlands) and a reverse transcrip-
tase step with Superscript III reverse transcriptase (Invitro-
gen, Merelbeke, Belgium), real-time PCR was performed on
a Rotor-Gene 3000 (Qiagen), amplifying a highly conserved
region of the 5¢-untranslated region of the enterovirus gen-
ome [9]. The presence of enterovirus was conﬁrmed by
PCR in this second PD sample, but at this time the culture
remained negative. Two days later (day 10), a blood sample
was also positive for enterovirus by PCR. A positive sample
was sent to the reference centre (Laboratory of Clinical
Virology, Rega Institute, Catholic University Leuven) for con-
ﬁrmation and typing of the virus strain by means of VP1
sequencing. The viral strain was identiﬁed as coxsackievi-
rus B1 by the reference laboratory. Serological testing for
enterovirus antibodies (complement ﬁxation test; Serion
Immundiagnostica, Wu¨rzburg, Germany) showed a two-fold
rise in titre from day 1 to day 10. The anti-inﬂammatory
therapy was continued. The CRP level and number of PD
efﬂuent leukocytes gradually decreased. On day 13, the
patient was discharged without complications.
Discussion
The majority of peritonitis episodes in PD can be ascribed to
Gram-positive bacteria of the skin and, to a minor degree, to
Gram-negative bacteria presumably originating from the
enteric ﬂora. About 20% of cultures remain negative. These
culture-negative cases can be ascribed to inadequate culture
techniques, prior antimicrobial therapy, fastidious organisms,
or chemical substances [1]. However, as diagnostic tests for
viral pathogens are not routinely performed on PD efﬂuent,
the role of viruses in CAPD peritonitis might be underesti-
mated. On the other hand, Pomeranz et al. [10] found a non-
interferon anti-viral factor in PD efﬂuents that may explain, in
part, the rarity of clinical viral peritonitis. HIV, hepatitis C virus
or cytomegalovirus DNA has been detected in PD efﬂuent of
chronically infected CAPD patients with and without peritoni-
tis [11–13]. DNA/RNA contamination from plasma should be
considered in cases of inﬂammation, particularly for viruses
with a high viral load, such as hepatitis C virus.
Our literature search revealed seven cases of viral peritoni-
tis in patients undergoing CAPD [2–8]. The characteristics of
the cases, including our case, are given in Table 1. Some com-
mon features can be seen. The clinical course in our patient
(fever, malaise, and clearance without antimicrobial treatment)
and a number of laboratory features (repeated negative bacte-
rial and mycobacterial cultures, slight leukopenia, PD efﬂuent
monocytosis (or absence of polymorphonuclear leukocytes,
the hallmark of bacterial peritonitis), and a rise in enterovirus
antibody titre) pointed to a viral infection. Coxsackievirus
infection was demonstrated by PCR and viral culture of PD
efﬂuent. As in the case reported by Struijk et al. [2], the clinical
picture and the history of viral infection of the granddaughter
triggered the physician to test the PD efﬂuent for viruses.
Transmission of enteroviruses is predominantly faeco-oral.
Longitudinal studies have demonstrated that secondary infec-
tions occur in >50% of susceptible household contacts [14].
During the course of a systemic viral illness, enterovirus
spreads by the haematogeneous route throughout the body.
This often results in a biphasic illness [15], as demonstrated in
our patient and the case with coxsackievirus pancreatitis [3].
Close contact and faeco-oral transmission were very plausible,
but, as no samples from the child were available, this hypothe-
sis could not be proven.
This case demonstrates that, when a viral aetiology of
CAPD-associated peritonitis is suspected, viral culture and,
preferably, PCR of the PD efﬂuent leads to the diagnosis.
PCR is a more rapid method, and has shown superior sensi-
tivity [16]. Culture and PCR of stool and respiratory speci-
mens are considered to be more sensitive. As the initial
suspicion of viral peritonitis was rather low, these specimens
were only tested later (after the active infection period
(day 13)). Cultures remained negative, and PCR on the respi-
ratory sample showed inhibition. Serological testing for
enterovirus antibodies should be performed on baseline and
convalescent samples, and in order for an acute infection to
be documented, a signiﬁcant rise in antibody titre (four-fold)
followed by a decrease in the convalescent phase should be
demonstrated [2]. Unfortunately, we were not able to dem-
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onstrate this in our case, possibly because of the short time
period between the paired samples (10 days). PD efﬂuent
leukocytosis, predominantly lymphocytic or monocytic, was
also reported in ﬁve of seven other published cases of viral
CAPD peritonitis [2–8].
In conclusion, although a viral aetiology in CAPD-related
infections is rare [1], viral peritonitis can occur in CAPD
patients during the course of an acute systemic viral illness.
Currently, virology tests are available to conﬁrm the diagno-
sis and avoid unnecessary days of antibiotic therapy. Intrave-
nous immunoglobulin therapy has been used for serious
enterovirus infections, but the evidence is limited. There
could be a beneﬁcial effect for neonates and children with
coxsackievirus myocarditis [17].
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Complement ﬁxation
test (serum)
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antibody titre rise at
)1 week and
+2 weeks
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Acute pancreatitis Complement ﬁxation
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Pauwels, 2011
(present case)
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(day 0 to day 10)
CMV, cytomegalovirus; HSV, herpes simplex virus; PD, peritoneal dialysis.
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